scPharmaceuticals Inc expected to post a loss of 31  cents a share - Earnings Preview

Scpharmaceuticals

06/05/2022 19:37

* scPharmaceuticals Inc  SCPH.OQ   SCPH.O  is expected
to show no
change in quarterly revenue when it reports  results on May 10
(estimated). 
    * ​Refinitiv's mean analyst estimate for scPharmaceuticals
Inc is
for a loss of 31 cents per share. For the same quarter last
year, the company reported a loss of 26 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
scPharmaceuticals
Inc is $11​, above​ its last closing price of $5.25. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  -0.32       -0.34      -0.27     Beat    21.4
 Sep. 30 2021  -0.31       -0.31      -0.24     Beat    23.4
 Jun. 30 2021  -0.30       -0.30      -0.26     Beat    13.3​
 Mar. 31 2021  -0.30       -0.30      -0.26     Beat    13.3
 ​​Dec.        -0.36       -0.36      -0.28     Beat    22.9
 31 2020                                                
 Sep. 30 2020  -0.38       -0.38      -0.33     Beat    13.7​
 Jun. 30 2020  -0.42       -0.42      -0.36     Beat    14.8
 Mar. 31 2020  -0.53       -0.54      -0.35     Beat    34.9
 This summary was machine generated May 6 at 18:37 GMT.  All
figures in US dollars  unless otherwise stated